Document Detail

Growth hormone (GH) responses to GH-releasing peptide and to GH-releasing hormone in GH-deficient children.
MedLine Citation:
PMID:  7745018     Owner:  NLM     Status:  MEDLINE    
The GH-releasing peptides (GHRPs) are a family of hexa- and heptapeptides that specifically stimulate GH secretion in normal adults and children. They would be an attractive potential form of therapy for GH deficiency (GHD) if they are also active in these patients. Their action, however, appears to result at least in part through hypothalamic responses, which may be impaired in GHD, and their ability to evoke a GH response in these patients must therefore be directly examined. We studied GH responses to the heptapeptide GHRP-1 in 22 prepubertal children with previously documented GHD and growth failure and compared them to responses to GHRH and the two peptides administered together. Patients received 1 microgram/kg GHRH-(1-44)NH2, 1 microgram/kg GHRP-1, or both, in random order. Tests were separated by at least 1 week. GHRP-1 evoked a significant GH response in 60% of the patients, comparable to the 68% who responded to GHRH. The magnitudes of the peak responses were similar (7.5 +/- 8.0 micrograms/L to GHRP-1 and 11.2 +/- 12.1 to GHRH), although the duration of the GH rise was briefer after GHRP-1. Both responses were lower than those previously observed in normal subjects. There was a marked synergy in responses when the two were given together; the GH peak (34.2 +/- 44.8 micrograms/L) significantly exceeded the sum of the individual responses, and the proportion of patients who responded (86%) was also higher. Thus, despite the absence of endogenous GHRH reflexes in most patients with GHD, these children can respond to GHRP-1 similarly to GHRH, and GHRP-1 can markedly enhance the response to GHRH. These results suggest that GHRPs or their analogs could form the basis for therapy of GHD.
V Mericq; F Cassorla; H Garcia; A Avila; C Y Bowers; G R Merriam
Related Documents :
9920068 - Serum levels of 20-kilodalton human growth hormone (gh) are parallel those of 22-kiloda...
15757848 - Serum markers of gh and insulin action in 12-year-old children born small for gestation...
14671408 - Insulin-like growth factors and their binding proteins in children born small for gesta...
780368 - The response of pituitary gonadotropes to a constant infusion of luteinizing hormone-re...
24470698 - Long-term changes in neurocognition and behavior following treatment of sleep disordere...
19048298 - Restless legs syndrome in pediatric patients with chronic kidney disease.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  80     ISSN:  0021-972X     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  1995 May 
Date Detail:
Created Date:  1995-06-15     Completed Date:  1995-06-15     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1681-4     Citation Subset:  AIM; IM    
Institute of Maternal and Child Research (IDIMI), University of Chile, Santiago.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Child, Preschool
Growth Hormone / deficiency*,  metabolism*
Growth Hormone-Releasing Hormone / therapeutic use*
Oligopeptides / therapeutic use*
Reg. No./Substance:
0/Oligopeptides; 87616-84-0/growth hormone releasing hexapeptide; 9002-72-6/Growth Hormone; 9034-39-3/Growth Hormone-Releasing Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prohormones in adrenal venous effluent in patients with primary hyperaldosteronism.
Next Document:  Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women.